Oct 13 (Reuters) - Pfizer (PFE.N) on Friday slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to lower-than-expected sales of its COVID-19 vaccine and treatment.
Unconfigured Ad Widget
Collapse
|
|
|
|
|
|
|
|
Pfizer cash cow is running out of milk
Collapse
X
-
They, and other Pharma companies, weren't doing well before COVID? They were ripping off the public with ridiculously high drug cost.
So now they have to return those levels. Oh boohoo.Comment
-
so that's why they have travis swift promoting their product...
sigpicOriginally posted by dunndealStop digging.iTraderOriginally posted by BrassCaseI only buy fireworks from Three Finger Willie over at One Eyed Jack's Fireworks.
https://www.calguns.net/calgunforum/....php?t=1884858Comment
-
Maybe if they offer some free pot or french fries again business will pick up.__________________________________________________ _____________
sigpicComment
-
Yeah, and PFE is now near a 52-week low and lost 46% of its value since the peak in December 2021.Comment
-
Pfizer was selling Paxlovid to the Feds for $529 and will charge insurance companies $1390 in 2024.
I guess you can chalk that up to volume discounts. That or the FDA / CDC kickbacks were so expensive they have to recoup their costs via the private sector.Send Lawyers, Guns and Money - On second thought, hold the Lawyers.Comment
Calguns.net Statistics
Collapse
Topics: 1,862,645
Posts: 25,096,346
Members: 355,415
Active Members: 4,538
Welcome to our newest member, scentedtrunk.
What's Going On
Collapse
There are currently 5486 users online. 24 members and 5462 guests.
Most users ever online was 239,041 at 10:39 PM on 02-14-2026.

Comment